Tuesday, June 23, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Analysis

Lululemon Shares Tumble as Growth Forecast Slashed

Andreas Sommer by Andreas Sommer
September 9, 2025
in Analysis, Consumer & Luxury, Earnings
0
Lululemon Stock
0
SHARES
183
VIEWS
Share on FacebookShare on Twitter

The athletic apparel retailer Lululemon, once a darling of the sector, is facing significant headwinds. A stark downward revision of its full-year guidance has rattled investor confidence, revealing deep-seated operational challenges within its crucial North American business. The announcement has prompted a critical reevaluation of the company’s near-term prospects.

Guidance Shock Triggers Sell-Off

The catalyst for the recent sharp decline was the earnings report released on September 4. While the company managed to surpass analyst profit expectations for the quarter, this achievement was entirely overshadowed by a severe cut to its annual forecast. Management slashed its 2025 revenue outlook by approximately $300 million. More dramatically, its earnings per share guidance was reduced by nearly $2.

This disappointing revision is attributed to a confluence of factors. A noticeable softening in consumer demand within the U.S. market led to a 4% drop in comparable sales for the second quarter. Furthermore, the company is grappling with substantial tariff-related headwinds. CEO Calvin McDonald conceded that the brand’s casual product assortment had become “too predictable” and was failing to resonate with shoppers. The increased tariff burdens are projected to reduce the 2025 gross profit by a significant $240 million.

Market Experts Downgrade Ratings En Masse

The financial community’s response was swift and severe. Numerous prominent banks and research firms moved to downgrade their recommendations and price targets for the stock.

Should investors sell immediately? Or is it worth buying Lululemon?

Analysts at Telsey Advisory Group removed their “Outperform” rating and drastically reduced their target from $360 to $200. Wells Fargo analysts issued a new target of $160. William Blair similarly withdrew its “Outperform” assessment. In a contrasting move, Truist Securities maintained a “Buy” recommendation with a $290 price target, standing against the prevailing negative sentiment. The overall consensus, however, is clear: the collective rating from the 29 analysts covering Lululemon has now slipped to “Hold,” indicating widespread and persistent skepticism.

International Operations Provide a Silver Lining

Amid the gloom in North America, Lululemon’s international segment continues to be a notable bright spot. The company is anticipating robust growth of 20-25% in China for 2025, with other international markets expected to expand by roughly 20%. While this geographic diversification offers a partial buffer, it is currently insufficient to fully counterbalance the pronounced struggles in the U.S. and the financial impact of tariffs.

In response to these challenges, the management team has outlined a recovery strategy. A fundamental overhaul of the product portfolio is promised, with the proportion of new styles slated to increase from 23% to 35% by the spring of 2026. The company is counting on new innovations, such as its “Align No Line” pants, to reinvigorate consumer interest and drive a recovery.

The critical question remains whether these initiatives can successfully engineer a turnaround. Forthcoming quarterly results will be scrutinized for early signs that the new strategy is gaining traction or if the current downward trend is set to continue.

Ad

Lululemon Stock: Buy or Sell?! New Lululemon Analysis from June 23 delivers the answer:

The latest Lululemon figures speak for themselves: Urgent action needed for Lululemon investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from June 23.

Lululemon: Buy or sell? Read more here...

Tags: Lululemon
Andreas Sommer

Andreas Sommer

About Andreas Sommer Over 40 years of expertise in market analysis, chart technical analysis, and strategic investment advisory. With more than four decades of experience in banking and financial journalism, Andreas Sommer is recognized as one of the leading analysts in the German-speaking market. His deep understanding of market dynamics and technical analysis has helped countless investors navigate complex financial markets.
Areas of Expertise:
  • Technical Chart Analysis
  • Strategic Investment Advisory
  • Market Trend Analysis
  • Financial Journalism
Andreas brings unparalleled insights from his extensive career in banking and financial markets, making him a trusted voice for investors seeking professional guidance.

Related Posts

FALLBACK Stock
Analysis

Half of German Workers Eye Early Retirement as Demographic Shift Intensifies Labor Crunch

June 23, 2026
FALLBACK Stock
Analysis

From Travel Time to Mass Layoffs: European Courts Reshape Employer Obligations Across Borders

June 22, 2026
SPACE EXPLORATION TECHN-CL A Stock
Analysis

SpaceX’s $20 Billion Bond and $60 Billion AI Bet: A Test of Investor Conviction Amid ESG Doubts

June 22, 2026
Next Post
Lexicon Stock

Lexicon Pharmaceuticals Nears Critical Regulatory Milestone

Skyworks Stock

Leadership Shift at Skyworks Solutions Sparks Investor Interest

Cisco Stock

Cisco's AI Infrastructure Push: Strategic Moves and Market Implications

Recommended

Fair Isaac Stock

Fair Isaac Approaches Critical Earnings Report

8 months ago
CME stock news

Navigating Uncertainty: Analysts Provide Mixed Recommendations for Getinge AB amidst Market Volatility

3 years ago
Software-solutions-technology

MongoDB Stock Plummets on Bleak Q1 and FY25 Projections

2 years ago
Vicarious Surgical Stock

Vicarious Surgical Faces Setback as Human Trials for Surgical Robot Are Delayed

10 months ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Bloom Energy Broadcom Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Netflix Novo Nordisk Nvidia Ocugen Oracle Palantir PayPal Plug Power Realty Income Robinhood Rocket Lab USA Salesforce Strategy Synopsys Take-Two Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics XRP
No Result
View All Result

Highlights

Antitrust Gridlock Hits Ams Osram: Shares Slide 6.4% as Infineon Deal Stalls — Debt Refinancing Progress Softens the Blow

Nvidia’s Vera Rubin Launch Arrives as Sovereign AI Revenue Triples to $30 Billion

Half of German Workers Eye Early Retirement as Demographic Shift Intensifies Labor Crunch

Investor Faith and Doubt Collide as Alphabet Balances Berkshire’s $10 Billion Bet Against a Talent Exodus

DAX Pulls Back From Record Range as Asian Tech Rout and Index Mechanics Upend Sentiment

Silver Price Collapse Accelerates: $62.59 as Hawkish Fed and Thawing Tensions Trump Widening Deficit

Trending

Western Digital Stock
AI & Quantum Computing

Downgrade Triggers Sharp Pullback in Western Digital’s AI-Fueled Surge

by SiterGedge
June 23, 2026
0

Western Digital’s torrid run hit a sudden roadblock on Tuesday after Fox Advisors lowered its rating on...

Keel Stock

Keel Infrastructure Bets on a Power-Landlord Model as AI Demand Strains the Grid

June 23, 2026
Hochtief Stock

Hochtief’s Narrow Free Float Exacerbates Post-DAX Profit-Taking as AI and Nuclear Ambitions Swell

June 23, 2026
Ams Osram Stock

Antitrust Gridlock Hits Ams Osram: Shares Slide 6.4% as Infineon Deal Stalls — Debt Refinancing Progress Softens the Blow

June 23, 2026
Nvidia Stock

Nvidia’s Vera Rubin Launch Arrives as Sovereign AI Revenue Triples to $30 Billion

June 23, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Downgrade Triggers Sharp Pullback in Western Digital’s AI-Fueled Surge
  • Keel Infrastructure Bets on a Power-Landlord Model as AI Demand Strains the Grid
  • Hochtief’s Narrow Free Float Exacerbates Post-DAX Profit-Taking as AI and Nuclear Ambitions Swell

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com